Emeryville, CA
Summary
The company is focused on developing innovative therapeutic solutions by utilizing a proprietary technology platform that measures the functional activity of antibodies. This approach aims to discover and create antibodies that not only block disease targets but also modulate their activity, addressing a wide range of untreated diseases including obesity, cancer, and inflammatory conditions. Their technology leverages synthetic biology and artificial intelligence to enhance the discovery process and has been validated through partnerships with pharmaceutical companies.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
6.5 years — Since Jul 2018
Web Hosting
Platform
E-Mail Provider
Google GSuite
No vendors identified.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|